We Don't Just Use AI. We Create New Possibilities.
From Scientific Discovery to New Products and Market Opportunities.
We help businesses investigate new ideas, design innovative products, reduce development costs, and study their potential commercial success using AI, research, mathematics, and human expertise.
We Research. We Invent. We Design. We Analyze the Market. β Invent Better. Develop Smarter. Reduce Costs. Strengthen American Innovation.
mRNA Vaccine Design | Drug Discovery | Product Invention | Manufacturing Cost Optimization | Market Research
AI-powered R&D and innovation consulting for businesses β from in-silico biomedical research to product invention, affordable manufacturing, and full market feasibility studies.
"You Bring the Business Challenge. We Develop the Possibilities."
We offer more than AI-generated suggestions. Our goal is to deliver structured research concepts, technical blueprints, feasibility assessments, and practical innovation strategies.
All research services are in-silico and computational; results are project-specific and require independent verification. No guaranteed outcomes, savings, or rankings are claimed.
From Idea to Market β Powered by AI
One structured path from a business challenge to a commercially evaluated product strategy.
Alkhaleeli BioAI LLC provides research, consulting, and development blueprints. Physical manufacturing, testing, certifications, and commercialization require appropriate partners and professional validation. Results are project-specific; no guaranteed outcomes or savings are claimed.
Alkhaleeli BioAI LLCAI-Powered Drug Discovery, Product Innovation & R&D Solutions
From molecular research to next-generation product concepts, we help businesses explore innovative solutions using artificial intelligence, biotechnology, computational science, and engineering-driven research.
Our Mission: Alkhaleeli BioAI LLC helps organizations accelerate innovation, investigate new therapeutics, improve products, and develop scientifically informed research and development strategies β helping businesses move from ideas and challenges toward practical, high-quality development plans.
In-silico computational research services only.
Our Core Research Services
In-silico computational research services that help R&D teams investigate therapeutic concepts faster.
All services are in-silico R&D β not approved clinical treatments.
AI-Assisted Drug Discovery
Computational research blueprints that structure therapeutic target investigation, molecular analysis, and AI-supported candidate evaluation for drug-discovery concepts.
In-Silico mRNA Vaccine & Therapeutic Design
Computational research blueprints that organize antigen evaluation, construct assessment, and immunological modeling for mRNA vaccine and RNA therapeutic concepts.
Product Innovation & R&D Consulting
Turn Your Business Ideas Into Innovative Product Concepts β we help businesses develop new products, improve existing products, and solve technical challenges using AI-assisted research, engineering concepts, and computational modeling.
Our Computational Research Blueprints
Documented in-silico research blueprints built from uploaded source documents and original research reports β each with its objective, scientific background, design concept, methods, and mathematical analysis.
All examples are computational research documents. No research findings, experimental results, approvals, or clinical outcomes are claimed β only publicly authorized materials are shown.
Scientific Expertise & Research Collaboration
Combining Advanced Scientific Knowledge with Artificial Intelligence to Support Drug and Vaccine Research.
Bioinformatics & Computational Biology
Molecular Biology
Immunology & mRNA Vaccine Research
Drug Discovery & Pharmaceutical Research
These are scientific expertise categories for specialist collaboration. Individual specialists appear on this site only after their identity, qualifications, participation, permission, and company role have been confirmed β no names or credentials are presented until then.
Explore Scientific ExpertiseAI-Powered Research. Human-Reviewed Science.
Every final client research report follows a documented workflow that combines computational speed with human scientific judgment.
No AI-generated final client report is released without documented human scientific review.
Where specialist PhD review is required by the agreed scope, only a genuinely engaged, appropriately qualified expert is assigned.
Every approved report records the reviewer identity, approval date, and document version history.
Human scientific review is a quality process β it is not a substitute for laboratory or clinical validation.
Rami Five-Checkpoint Framework
A mathematically rigorous, AI-guided computational pipeline for designing personalized mRNA vaccine candidates β built case by case for cancer patients.
Personalized Cancer mRNA Vaccine Design
The R5CF is an in-silico software framework developed by Rami M. Alkhaleeli at Alkhaleeli BioAI LLC. It processes each patient's unique tumor genomic profile through five sequential mathematical checkpoints to computationally design a tailored mRNA vaccine candidate β from neoantigen identification all the way to manufacturing feasibility scoring.
What R5CF Covers
Computational research only. All outputs are theoretical and require experimental validation. The R5CF is protected under USPTO Provisional Patent Application No. 63/936,055 (Rami M. Alkhaleeli, 2025).
Our Story and Vision
Alkhaleeli BioAI LLC was founded in Yukon, Oklahoma to connect biological science with modern artificial intelligence and computational research β so that promising therapeutic ideas can be investigated faster, with transparent methods and responsible human judgment.
Mission
"To empower research and development teams with computational tools and scientific blueprints that make early-stage drug and vaccine research more efficient, accessible, and affordable."
Vision
"To help accelerate therapeutic research through biological knowledge, artificial intelligence, bioinformatics, mathematical modeling, and responsible human scientific judgment."
USPTO Patent Portfolio & Innovation Filings
Biotechnology β’ AI Diagnostics β’ mRNA Research β’ Biosensors β’ Energy Innovation
Rami M. Alkhaleeli's innovation portfolio includes one granted U.S. patent and multiple USPTO provisional patent applications across biomedical device design, AI-guided mRNA research, rapid immunoassay concepts, AI-designed biosensor platforms, and magneto-mechanical energy-harvesting technology.
Method and Apparatus for Improving Osseointegration, Functional Load, and Overall Strength of Intraosseous Implants
Rami M. Alkhaleeli, Founder and CEO of Alkhaleeli BioAI LLC, is a named co-inventor of U.S. Patent No. 11,058,521, assigned to the University of Central Oklahoma. This patent relates to implant-surface technologies designed to improve osseointegration and biological integration. This patent is presented as part of the founder's professional innovation background. It is not represented as intellectual property owned or licensed by Alkhaleeli BioAI LLC. No institutional endorsement or commercial partnership with UCO is implied.
View public patent recordAI-guided personalized mRNA cancer vaccines with CRISPR-based antigen validation
This provisional filing describes a research-only AI-guided workflow for identifying cancer-associated targets, prioritizing possible mRNA vaccine candidates, and using CRISPR-based concepts for antigen-validation research. This is an early-stage computational and experimental concept, not a clinical treatment or approved vaccine.
Lateral Flow Immunoassay Apparatus for Rapid Detection and Quantification of Allergen-Specific IgE Antibodies
This provisional filing focuses on a rapid lateral-flow immunoassay concept for detecting and estimating allergen-specific IgE antibodies. The goal is to support fast, accessible allergy-related screening research using a portable test-format concept.
Artificial Intelligence Designed Synthetic Binding Protein Colorimetric Biosensor Platform for Rapid Diagnostic Detection and Classification of Gram Negative Bacteria, Gram Positive Bacteria, and Fungal Pathogens
This provisional filing describes an AI-designed biosensor platform using synthetic binding proteins and colorimetric detection concepts to identify and classify bacterial and fungal pathogens. The concept is intended for research and prototype development, not clinical diagnostic use unless validated and cleared by regulators.
The Five-Stage Magneto-Mechanical RF Harvester for Battery-Free Phones
This provisional filing presents an energy-harvesting concept combining magneto-mechanical motion and RF-related energy-capture ideas for battery-free or emergency power applications. It represents early-stage engineering research into alternative micro-power generation.
USPTO Receipts & Patent Records
Important Disclaimer: Some records shown are provisional patent applications and are not issued patents. Provisional applications are early-stage USPTO filings and do not by themselves represent granted patent rights. Medical, scientific, diagnostic, and therapeutic concepts shown here are research-only and are not FDA-cleared, clinically validated, or intended for diagnosis, treatment, cure, or clinical decision-making unless specifically approved through the appropriate regulatory process.
Alkhaleeli BioAI LLC presents this portfolio for informational, educational, and research-innovation purposes. All medical and biotechnology concepts require laboratory validation, safety testing, regulatory review, and appropriate approvals before any clinical or commercial use.
Let's Make It Cheaper with AI β Without Compromising Quality
Smarter Design. Lower Costs. American Quality. Stronger Businesses.
The Founder's Story
"One day, I wanted to build an additional office space in my home. I received a contractor's quote of approximately $20,000.
I began exploring a different approach using mathematics, AI-assisted design, and cost estimation. My preliminary concept suggested that some of the work might be achievable for around $2,000, depending on the final design, materials, labor, permits, and construction requirements.
(The $2,000 figure is an unverified preliminary estimate β not a completed equivalent construction project or a guaranteed saving.)
That experience inspired a bigger question:
What if American businesses could use AI to design products, reduce waste, optimize manufacturing, and discover more affordable solutions while maintaining high quality?
That question became part of my vision for Alkhaleeli BioAI LLC." β Rami M. Alkhaleeli, Founder & CEO
Our Mission
We believe the United States can become even more competitive in manufacturing and product development by combining artificial intelligence, engineering, mathematical modeling, and American craftsmanship.
Our Promise
Reduce Waste. Improve Design. Empower Workers. Strengthen American Industry.
AI is a tool to support human creativity, expertise, and productivityβnot replace the skilled people who make great products possible.
- Reduce unnecessary product-development and manufacturing costs.
- Improve existing products and develop innovative new concepts.
- Identify affordable materials and more efficient production methods.
- Use AI simulations and computational design to explore alternatives before expensive physical development.
- Strengthen American manufacturing and competitiveness.
- Support American workers, skilled labor, and high-quality production rather than simply replacing people with automation.
- Explore cost-effective solutions across biotechnology, consumer products, industrial design, manufacturing, and other appropriate industries.
Consulting Services
Projects outside our internal technical expertise will require collaboration with appropriately qualified professionals.
Cost reductions and quality improvements are project-specific and depend on independent verification, applicable engineering standards, labor, materials, and regulatory requirements. Preliminary estimates are not guaranteed project prices.
Watch Our Research in Action
Demos, framework walkthroughs and educational videos from the Alkhaleeli BioAI research tools.
PersonalVax AI: Case-by-Case Cancer Research Tool
Testing PersonalVax AI, a research-only educational app for mRNA cancer vaccine design concepts. Demo workflow: Normal vs tumor sequence β mutation detection β neoepitope screening β R5CF candidate ranking.
R5CF Framework Overview
A walkthrough of the Rami Five-Checkpoint Framework (R5CF) β the AI-guided computational pipeline for personalized mRNA vaccine candidate design, from neoantigen identification to manufacturing feasibility.
Can We Stop Amputation Before It Starts?
RamiBlocker Lab in action β an AI-guided computational research tool for exploring diabetic-foot and infection-risk research concepts, aiming to help stop amputation before it starts.
In Silico mRNA Vaccine Example β Nipah Virus
Example work: an in silico mRNA vaccine design study for the Nipah virus β computational candidate design and analysis from the Alkhaleeli BioAI research team.
Who We Are β Alkhaleeli BioAI LLC
A short introduction to Alkhaleeli BioAI LLC β who we are and our AI-driven approach to medicine, biomedical research and mRNA science.
Research & Educational Use Only
All videos demonstrate computational, research-only tools. Nothing shown is intended for clinical use, patient care or medical decision-making. All outputs are theoretical and require experimental validation.
"Have an idea, technical challenge, or product you want to improve? Alkhaleeli BioAI LLC can help you investigate the possibilities and build a research-driven path toward innovation."
Start Your R&D or Product Innovation Project Today.
AI-powered in silico biotechnology research. Experimental and clinical validation are outside the scope of our computational services.